Global transplant footprint Organ Recovery Systems serves 400+ transplant programs across 49 countries, indicating a broad international market and potential for expanding service contracts, spare parts, and training programs in new regions.

Leading edge portfolio With LifePort Kidney Transporter and LifePort Liver Transporter as flagship products, there are ongoing opportunities to upsell complementary preservation solutions, service agreements, and expansion into donor organ preservation modalities.

Awarded credibility Recognition in Fast Company’s Innovation by Design and Best in Biz Awards enhances credibility with hospitals and procurement teams, supporting competitive positioning and facilitating introductions to new accounts.

Strategic partnerships Collaborations with academic and clinical centers (e.g., UCLouvain and Saint-Luc) suggest a pathway for co-development deals, clinical trials, and pilots that can be leveraged to secure broader adoption of LifePort solutions.

Growth potential Revenue in the mid-range tens to hundreds of millions with a moderate employee base signals scalability opportunities through regional sales expansions, targeted go-to-market programs, and expanded tech-enabled customer support.